PetMed Express
PETS
193 hedge funds and large institutions have $447M invested in PetMed Express in 2021 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 51 increasing their positions, 74 reducing their positions, and 31 closing their positions.
3% less funds holding
Funds holding: 198 → 193 (-5)
5.35% less ownership
Funds ownership: 87.38% → 82.03% (-5.3%)
13% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 31
21% less capital invested
Capital invested by funds: $563M → $447M (-$116M)
31% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 74
45% less call options, than puts
Call options by funds: $23.7M | Put options by funds: $43.2M
Top Buyers
Top Sellers
| 1 |
ProShare Advisors
Bethesda,
Maryland
|
-$16.4M |
| 2 |
Goldman Sachs
New York
|
-$4.19M |
| 3 |
PCM
Penserra Capital Management
Orinda,
California
|
-$3.84M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.13M |
| 5 |
Amundi
Paris,
France
|
-$3.04M |
PETS Hedge Fund Activity: Q3 2021 in Review
193 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in PetMed Express (PETS) for Q3 2021, worth a combined $447M — down 21% from $563M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of PETS and 27 opened new positions — a net loss of 4 holders — while 74 trimmed existing stakes and 51 added.
The largest buyer was Allianz Asset Management, adding an estimated $3.06M. The largest seller was ProShare Advisors, cutting an estimated $16.4M.
- 193 institutional investors held PetMed Express (PETS) as of Q3 2021, down from 198 in Q2 2021.
- Funds reported $447M of PetMed Express stock for Q3 2021, down 21% quarter-over-quarter.
- 27 funds opened new PetMed Express positions in Q3 2021 and 31 closed out, a net change of -4 holders.
- The largest PetMed Express buyer in Q3 2021 was Allianz Asset Management, an estimated $3.06M added.
- The largest PetMed Express seller in Q3 2021 was ProShare Advisors, an estimated $16.4M sold.
Based on aggregated 13F filings for Q3 2021.